CDKN2A and central nervous system cancer: The frequent activation of RAS, PI3K/PTEN/AKT, RB/CDKN2A-p16INK4a, and TP53/MDM2/MDM4/CDKN2A-p14ARF pathways are implicated in glioma proliferation (55, 56).